Grigg, M J <br/><br/>
A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial).  [electronic resource] 

 -  BMJ open  Aug 2014 
 - e006005 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2044-6055 
<br/><br/><label>Standard No.: </label>10.1136/bmjopen-2014-006005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimalarials--therapeutic use<br/>Artemisinins--therapeutic use<br/>Artesunate<br/>Chloroquine--therapeutic use<br/>Female<br/>Humans<br/>Malaria--drug therapy<br/>Malaysia<br/>Male<br/>Mefloquine--therapeutic use<br/>Plasmodium knowlesi<br/>Research Design<br/>Severity of Illness Index